The global disposable syringes market size is expected to reach US$ 11.56 billion by 2030 from US$ 6.38 billion in 2020 and is expected to grow at an impressive double-digit rate of 5.6% from 2021 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global disposable syringes Market for the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.
Disposable syringes are very common within the healthcare industry. They are relatively inexpensive and easy to mass-manufacture allowing for anadvanced level of availability. Usually speaking, syringes are devices used to insert or draw formulations from a bigger body. Usually functioned via a piston-pump arrangement, they are the chief method by which a clinician or nurse administers medication to the patients. Previously, syringes were cleaned and reprocessed. However, in the modern periods the use-and-throw syringe has increased in popularity over the outdated reusable type of syringe. The prime difference being that a use-and-throw syringe is envisioned for one-time usage and is then thrown away, typically into aninfection unit. While very simple in idea, syringes have numerous variants and fragments which are transposable dependent on the proposed use of the syringe. Usually, these are features which might vary reliant on on the syringe being employed.
Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1209
Growth Factors
Factors such as increasing number of patients at risk of developing stroke, increasing patient awareness, increased health care expenditure, large pool of geriatric population, growing usage of injectable drugs, higher bioavailability of injectable drugs, growing instances of needlestick injuries, increasing cases of chronic disorders such as diabetes and chronic, and increased preference of intravenous route of drug administration are driving the growth of disposable syringes market. Moreover, Additional features that are expected to fuel this businessare integration of latest technologies for disposable syringes and growing investment by major players.
As per WHO (World Health Organization), the number of cancer cases globally reached 19.3 million in the year 2020. With increasing number of cancer cases, the demand for disposable syringes is also growing due to its predominant use in medical care for several cancers like ovarian cancer, breast cancer, non-small cell lung cancer, lung cancer, AIDS related Kaposi’s sarcoma, cervical cancer, prostate cancer, pancreatic cancer, esophageal cancer, stomach cancer, and testicular cancer among others. It is expected that between the years 2018 and 2040, the extent of patients needing first-line chemotherapy worldwide each year will surge 53% that is to 15 million from 9.8 million. The growth in chemotherapy demand will principally be an outcome of population rise and projected variations in the dispersal of cancer types by nation which is expected to boost the requirement for the disposable syringes in the near future.
Report Highlights:
- Among the type segment, safety syringes dominated the overall market in 2020. High use of safety syringes for safe transfer of medications and low-cost difference are the foremost factors attributing to its large market share.
- The therapeutic injections segment accounted for the major share of revenue in the patient type segment with more than 71% share in 2020 due to high use of disposable syringes for the administration of therapeutic medications. Moreover, high incidence of disorders such as malaria, dengue, HIV, tuberculosis, and typhoid are expected to augment the demand for disposable syringes in the near future. Launch of new injectable drugs for the treatment of chronic disorders will play an important role in retaining the market dominance of therapeutic injections over the estimated period.
- Baxter International, Inc., Becton, Dickinson and Company, and Novo Nordisk accounted for a significant share of the global disposable syringes market.
Why should you invest in this report?
If you are aiming to enter the global disposable syringes market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for disposable syringes are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Regional Analysis:
The report includes information for Asia Pacific, North America, Latin America, Europe, Middle East, and Africa. In 2020, the North America dictated the globalindustry with a market stake of greater than 41%. The U.S. indicated the highest slice in North America principally due to increasing cases of cancer and early adoption of latest healthcare equipment’s. Moreover, availability of latest healthcare infrastructure also supported the high market portion of North America.
Europe was the subsequent significant market chiefly due to presence of skilled physicians. Presence of major companies in the European region is also expected to lift the demand for disposable syringes in the anticipated time-span. The Asia Pacific region is projected to grow at the highest CAGR of around6.9% in the estimate period due to increasing healthcare expenditure. Latin America and Middle East and African region will display noticeable growth.
Key Market Players and Strategies:
The key companies functioning in the worldwide disposable syringes market are Fresenius Kabi, Covidien, Becton, Dickinson and Company, Flextronics International, Braun Medical, Inc., Novo Nordisk, Vita Needle Company, Baxter International, Inc., Retractable Technologies, Inc., UltiMed, Inc., Henke-Sass, Wolf, and Terumo Corporation among others.
Increased expenditure on research and progress along with acquisition, collaborations, and mergers are the significant strategies taken up by producers working in the international disposable syringes market. Moreover, leading companies are investing heavily on research for the development of new treatment techniques. Strategic associations in terms of authorizing and collaboration, allow businesses to co-develop and commercialize formulation. Companies have been investing in the discovery and R&D of medication given for disposable syringes.
Major Market Segments Covered:
By Type
- Conventional Syringes
- Safety Syringes
- Retractable Safety Syringes
- Non-retractable Safety Syringes
By Application
- Immunization Injections
- Therapeutic Injections
Regional Analysis:
The geographical analysis of the global disposable syringes market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American market is again segmented into the US, Canada, and Mexico. Coming to the European market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global disposable syringes Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global disposable syringes market in 2030?
- What is the expected CAGR for the disposable syringes market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global disposable syringes market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Disposable Syringes Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Disposable Syringes Market
5.1. Covid-19: Disposable Syringes Industry Impact
5.2. Disposable Syringes Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Disposable Syringes Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Disposable Syringes Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Disposable Syringes Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing patient awareness
6.1.1.2. Increased health care expenditure
6.1.2. Market Restraints
6.1.2.1. High cost
6.1.3. Market Opportunities
6.1.3.1. Large pool of geriatric population
Chapter 7. Global Disposable Syringes Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Disposable Syringes Market Revenue by Market Players (2016 -2019)
7.1.1.2. Disposable Syringes Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Disposable Syringes Market, By Type
8.1. Disposable Syringes Market, by Type, 2017-2030
8.1.1. Conventional Syringes
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Safety Syringes
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Retractable Safety Syringes
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Non-Retractable Safety Syringes
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Disposable Syringes Market, By Application
9.1. Disposable Syringes Market, by Application, 2017-2030
9.1.1. Immunization Injections
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Therapeutic Injections
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Disposable Syringes Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue Forecast by Type(2017-2030)
10.1.2. Market Revenue Forecast by Application (2017-2030)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2017-2030)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2017-2030)
10.2. Europe
10.2.1. Market Revenue Forecast by Type (2017-2030)
10.2.2. Market Revenue Forecast by Application (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2017-2030)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2017-2030)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Type (2017-2030)
10.3.2. Market Revenue Forecast by Application (2017-2030)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2017-2030)
10.4. LATAM
10.4.1. Market Revenue Forecast by Type (2017-2030)
10.4.2. Market Revenue Forecast by Application (2017-2030)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2017-2030)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2017-2030)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Type (2017-2030)
10.5.2. Market Revenue Forecast by Application (2017-2030)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2017-2030)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2017-2030)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2017-2030)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2017-2030)
Chapter 11. Company Profiles
11.1. Fresenius Kabi AG
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Type Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2016 - 2019)
11.1.4. Recent Developments and Strategies
11.2. Becton, Dickinson and Company
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Type Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2016 - 2019)
11.2.4. Recent Developments and Strategies
11.3. Flextronics International
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Type Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2016 - 2019)
11.3.4. Recent Developments and Strategies
11.4. Covidien
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Type Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2016 - 2019)
11.4.4. Recent Developments and Strategies
11.5. Braun Medical, Inc.
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Type Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2016 - 2019)
11.5.4. Recent Developments and Strategies
11.6. Novo Nordisk
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Type Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2016 - 2019)
11.6.4. Recent Developments and Strategies
11.7. Vita Needle Company
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Type Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2016 - 2019)
11.7.4. Recent Developments and Strategies
11.8. Baxter International, Inc.
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Type Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2016 - 2019)
11.8.4. Recent Developments and Strategies
11.9. Retractable Technologies, Inc.
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Type Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2016 - 2019)
11.9.4. Recent Developments and Strategies
11.10. Henke-Sass, Wolf
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Type Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2016 - 2019)
11.10.4. Recent Developments and Strategies
11.11. UltiMed, Inc.
11.11.1. Company Overview, Business Information, Regional Presence
11.11.2. Product Portfolio Analysis
11.11.2.1. Type Details, Specification, Application
11.11.3. Revenue, Price, and Gross Margin (2016 - 2019)
11.11.4. Recent Developments and Strategies
11.12. Terumo Corporation
11.12.1. Company Overview, Business Information, Regional Presence
11.12.2. Product Portfolio Analysis
11.12.2.1. Type Details, Specification, Application
11.12.3. Revenue, Price, and Gross Margin (2016 - 2019)
11.12.4. Recent Developments and Strategies
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1209
About Us:
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and among different ventures present globally.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments